Hematology NewsSimilar results for once- or twice-weekly carfilzomib in MMFebruary 23, 2019Multiple MyelomaLymphoma & Plasma Cell DisordersRare Diseases
Hematology NewsTrial supports less aggressive myeloma treatmentFebruary 8, 2019Multiple MyelomaLymphoma & Plasma Cell DisordersRare Diseases
Hematology NewsMeta-analysis: IVIG bests anti-D on platelet count in pediatric ITPFebruary 5, 2019Bleeding DisordersRare DiseasesPediatrics
Oncology PracticeTop cancer advance: Treatment of rare diseasesFebruary 1, 2019Rare DiseasesPractice ManagementBusiness of Medicine
Hematology NewsObinutuzumab-based regimens yield durable remissions in CLLJanuary 16, 2019CLLLeukemia, Myelodysplasia, TransplantationRare Diseases
Hematology NewsALL chemotherapy looks effective in mixed phenotype leukemiaJanuary 3, 2019ALLLeukemia, Myelodysplasia, TransplantationPediatricsRare Diseases
Hematology NewsFDA approves ravulizumab for treatment of paroxysmal nocturnal hemoglobinuriaDecember 21, 2018AnemiaRare Diseases
Oncology PracticeFDA approves Elzonris for blastic plasmacytoid dendritic cell neoplasmDecember 21, 2018Rare DiseasesALLLeukemia, Myelodysplasia, Transplantation
Hematology NewsParental leave for residentsDecember 13, 2018Rare DiseasesLifestyleBusiness of MedicinePreventive CarePractice Management
Hematology News2018: A banner year for hematology drug approvalsDecember 5, 2018Business of MedicineCLLAggressive LymphomasMixed TopicsPractice ManagementLymphoma & Plasma Cell DisordersRare Diseases
Oncology PracticeFDA approves larotrectinib for cancers with NTRK gene fusionsNovember 27, 2018Sarcoma & GISTRare DiseasesFibrosarcoma
Oncology PracticeTechnology offers new tools, challenges for rare-disease patientsOctober 26, 2018Rare Diseases
Oncology PracticeEducation and support enhance care for rare-disease patientsOctober 26, 2018Rare Diseases
